1498 — PuraPharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual cashflow statement for PuraPharm, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	40.2	-117	-119	-102	-29.1
Depreciation
Amortisation
Non-Cash Items	21.6	170	81.9	73.3	24.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	10.5	-118	77.1	60	53.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	120	-14.5	88.5	79.6	104
Capital Expenditures	-82.8	-6.56	-23.6	-21.7	-16.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-9.26	12.6	-7.69	3.46	4.67
Sale of Fixed Assets
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-92.1	6	-31.2	-18.2	-11.7
Financing Cash Flow Items	-40.4	-27	-18.6	-35.1	-20.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3.61	-16	-35.6	-122	-86.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	25.4	-18.3	16.2	-55.7	-7.33